Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report

• DOI: 10.1111/ajd.13803
• Publication Date: 2022-02-09T16:50:28Z
• Authors: Jenny SW Yun; Laura Scardamaglia; Chin‐Guan Tan; Christopher J McC...
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 616; Pemphigoid, Bullous; 610; Graft vs Host Disease; Humans; Psoriasis; Antibodies, Monoclonal, Humanized; 3. Good health

ABSTRACT Since the concurrence of bullous pemphigoid (BP) and psoriasis was first reported in 1929, an increasing number studies has been published to analyse their relationship recent years. However, pathogenesis is not yet well understood, coexistence two conditions imposes a difficult therapeutic challenge. This case report demonstrates secukinumab achieving dramatic clinical improvement both chronic active BP.